| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 08/14/2007 | US7256181 In situ supplying interferons; gene expression; gene therapy |
| 08/14/2007 | US7256180 Using Pluronics; inducting immunology response |
| 08/14/2007 | US7256043 Transfection complexes |
| 08/14/2007 | US7256037 Modified vaccinia Ankara expressing p53 in cancer immunotherapy |
| 08/14/2007 | US7256036 Blocking receptor binding; gene therapy; gastrin releasing peptide |
| 08/14/2007 | US7256028 Methods for screening compounds that modulate lipid metabolism |
| 08/14/2007 | US7256010 Nucleic acid sequences encoding melanoma associated antigen molecules, aminotransferase molecules, ATPase molecules, acyltransferase molecules, pyridoxal-phosphate dependant enzyme molecules and uses therefor |
| 08/14/2007 | US7255988 Use of α 1-antichymotrypsin polypeptides, or nucleic acids encoding them, or of a cell which is expressing an ACT polypeptide, or a nucleic acid encoding it, for treatment and/or prevention of diabetes-associated and/or arterial poorly healing wounds and for identifying pharmacologically active substances |
| 08/14/2007 | US7255879 Extracting and recovering embryonic-like stem cells, including pluripotent or multipotent stem cells, from an exsanguinated human placenta; use of the isolated and perfused placenta as a bioreactor in which to propagate endogenous/exogenous cells |
| 08/14/2007 | US7255862 ALVAC/FIV constructs |
| 08/14/2007 | US7255857 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 08/14/2007 | US7255856 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 08/14/2007 | CA2166328C Prostacyclin synthase derived from human |
| 08/09/2007 | WO2007090097A2 Systems and methods for targeted and controlled delivery of agents |
| 08/09/2007 | WO2007089871A2 Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders |
| 08/09/2007 | WO2007089870A2 Vaccine delivery compositions and methods of use |
| 08/09/2007 | WO2007089783A2 Tat-044 and methods of assessing and treating cancer |
| 08/09/2007 | WO2007089762A2 Devices for selective recruitment, isolation, activation, and/or elimination of various cell populations |
| 08/09/2007 | WO2007089733A2 Regimens for treatment of conditions related to estrogen deficiency |
| 08/09/2007 | WO2007089632A2 Heparin and heparan sulfate binding chimeric vectors |
| 08/09/2007 | WO2007089607A2 Rna silencing agents for use in therapy and nanotransporters for efficient delivery of same |
| 08/09/2007 | WO2007089584A2 Compositions and their uses directed to huntingtin |
| 08/09/2007 | WO2007088900A1 Double-stranded rna inducing cell death |
| 08/09/2007 | WO2007021886A3 Truncated memapsin 2 for use for treating alzheimer's disease |
| 08/09/2007 | US20070186299 Knockout mouse for the tumor suppressor gene ANX7 |
| 08/09/2007 | US20070186295 TAT-036 and methods of assessing and treating cancer |
| 08/09/2007 | US20070186294 TAT-030 and methods of assessing and treating cancer |
| 08/09/2007 | US20070186292 Methods for genetic diversification in gene conversion active cells |
| 08/09/2007 | US20070185050 Double-stranded RNA (dsRNA) and method of use for inhibiting expression of a fusion gene |
| 08/09/2007 | US20070185049 Controlling gene expression |
| 08/09/2007 | US20070185048 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 08/09/2007 | US20070185047 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 08/09/2007 | US20070185046 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 08/09/2007 | US20070185045 Inhibitors of 2-oxoglutarate dioxygenase as gamma globin inducers |
| 08/09/2007 | US20070185044 Inhibiting SARS virus infection or replication in cell or tissue by contacting cell or tissue with an antisense compound 12 to 30 nucleobases in length targeted to a nucleic acid molecule encoding ACE2, wherein compound is specifically hybridizable with nucleic acid molecule encoding ACE2 |
| 08/09/2007 | US20070185043 Rna interference mediated inhibition of nogo and nogo receptor gene expression using short interfering nucleic acid (sina) |
| 08/09/2007 | US20070185042 Sirna based methods for treating alzheimer's disease |
| 08/09/2007 | US20070185020 Methods and compositions for treating disorders of the extracellular matrix |
| 08/09/2007 | US20070185010 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184485 Method of diagnosing diseases relating to endometriosis |
| 08/09/2007 | US20070184461 Novel Polypeptide Hormone Phosphatonin |
| 08/09/2007 | US20070184438 Methods and nucleic acids for the analysis of colorectal cell proliferative disorders |
| 08/09/2007 | US20070184096 Stable Therapeutic Formulations |
| 08/09/2007 | US20070184084 Implantable elastomeric caprolactone depot compositions and uses thereof |
| 08/09/2007 | US20070184070 Recombinant toxin fragments |
| 08/09/2007 | US20070184068 Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| 08/09/2007 | US20070184055 Treatment with anti-erbb2 antibodies |
| 08/09/2007 | US20070184042 Method of cancer treatment by p53 protein control |
| 08/09/2007 | US20070184038 Therapeutic uses for mesenchymal stromal cells |
| 08/09/2007 | US20070184037 T cell immune response inhibitor |
| 08/09/2007 | US20070184036 Isolated cd4+ t cells defined by cmrf-35 |
| 08/09/2007 | US20070184028 preparation comprising the vector system of the invention and an interfering agent; treatment of hemophilia, diabetes, rheumatoid arthritis, genetic immunodeficiency, and graft versus host disease |
| 08/09/2007 | US20070184027 Evacuating a clot from a blood vessel in a mammal; isolating a segment around evacuation site; infecting a segment of a blood vessel in vitro using a gutless adenoviral vector comprising a polynucleotide encoding a thrombomodulin protein or its variant; grafting the virus-treated blood vessel in mammal |
| 08/09/2007 | US20070184026 Methods, Agents, and Compound Screening Assays for Inducing Differentiation of Undifferentiated Mammalian Cells into Osteoblasts |
| 08/09/2007 | US20070184025 Chimaeric vector system |
| 08/09/2007 | US20070184021 Use of caspase inhibitors as a therapeutic agent against radiation-induced injury |
| 08/09/2007 | US20070183974 Method and apparatus for production of a skin graft and the graft produced thereby |
| 08/09/2007 | CA2638908A1 Compositions and their uses directed to huntingtin |
| 08/09/2007 | CA2635718A1 Methods of using hedgehog kinase antagonists to inhibit hedgehog signaling and to treat hedgehog mediated disorders |
| 08/09/2007 | CA2634286A1 Compositions and methods for regulating complement system |
| 08/08/2007 | EP1816205A1 Serotype of adenovirus and uses thereof |
| 08/08/2007 | EP1816204A1 Recombinant Adenovirus of the Ad26 serotype |
| 08/08/2007 | EP1815866A1 Remedy or preventive for ischemic cardiac disease or ischemic cardiac myopathy |
| 08/08/2007 | EP1815862A1 Isolated stromal cells for use in the tretment of diseases of the central nervous system |
| 08/08/2007 | EP1815848A1 Antibody fragment-targeted immunoliposomes for systemic gene delivery |
| 08/08/2007 | EP1814989A2 Methods and compositions for rna interference |
| 08/08/2007 | EP1814907A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 08/08/2007 | EP1814897A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 08/08/2007 | EP1814595A1 Treatment of cancer with a combination of an agent that perturbs the egf signaling pathway and an oligonucleotide that reduces clusterin levels |
| 08/08/2007 | EP1814594A2 Vector comprising polymer modified sirna liposomes |
| 08/08/2007 | EP1480671B1 Recombinant rsv virus expression systems and vaccines |
| 08/08/2007 | EP1456382B1 Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of using nonglycosylated cyanovirins |
| 08/08/2007 | EP1267616B1 Methods of increasing hair growth by wnt polypeptide |
| 08/08/2007 | EP1211318B1 Paramyxoviruses comprising a modified transcription start sequence |
| 08/08/2007 | EP1187852B1 EXPRESSION AND EXPORT OF INTERFERON-ALPHA PROTEINS AS Fc FUSION PROTEINS |
| 08/08/2007 | EP1122306B1 Novel deoxyribonuclease, gene encoding the same and use thereof |
| 08/08/2007 | EP1113807B1 Cell mediated gene delivery using muscle derived cells for treating muscle- and bone-related injury or dysfunction |
| 08/08/2007 | EP1108035B1 Treatment of cervical cancer |
| 08/08/2007 | EP1100538B1 Kvlqt1 - a long qt syndrome |
| 08/08/2007 | EP1082444B1 Adeno-associated virus vectors and uses thereof |
| 08/08/2007 | EP0882065B1 Novel human metabotropic glutamate receptor |
| 08/08/2007 | CN1330767C Paramyxorividae virus vector defective in envelope gene |
| 08/08/2007 | CN1330765C Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
| 08/08/2007 | CN1330668C Antibodies to insulin-like growth factor I receptor |
| 08/08/2007 | CN101014701A Cartilage and bone repair composition. |
| 08/08/2007 | CN101014613A Chimpanzee adenovirus vaccine carriers |
| 08/08/2007 | CN101014608A Methods and compositions for the inhibition of gene expression |
| 08/08/2007 | CN101012463A HDAd/F carrier and method for preparation and use |
| 08/08/2007 | CN101012262A Nucleic acid molecule RTN4BSR32 and application in preparation of anti-cancer drugs |
| 08/08/2007 | CN101011584A Method for achieving persistent transgene expression |
| 08/08/2007 | CN101011583A Gene medicament for promoting mink growth |
| 08/08/2007 | CN101011582A Medicament for emergency treatment after hydrophobia exposition and emergency therapy at early stage of pathogenesis, and its preparing process |
| 08/08/2007 | CN101011577A Polyamide dendroid polymer nano particle loading survivin small molecule RNA |
| 08/07/2007 | US7253273 Polynucleotide encoding a protein comprising an engineered zinc finger DNA-binding domain |
| 08/07/2007 | US7253266 Polypeptides of FGF-CX |
| 08/07/2007 | US7253151 Genes of IL-12P40 subunit mutated for improving the activity of IL-12 and use thereof for DNA vaccine adjuvant |
| 08/07/2007 | US7253150 Gene delivery vehicle expressing the aptosis-inducing proteins VP2 and/or apoptin |
| 08/07/2007 | US7252997 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 08/07/2007 | US7252991 Retroviral packaging system, plasmids and packagable vector transcripts produced from high expression plasmids after stable or transient transfection in mammalian cells |
| 08/07/2007 | US7252989 A replicated and packaged vector construct inside a virion particle in the helper cell, able expressing a foreign gene in a mammalian cell; use in transfection |